DLB

Dolby Laboratories, Inc.
$49.41
+0.26 (+0.53%)
Mkt Cap 4.68B
Volume 124,692
52W Range 48.26-77
Sector Technology
Beta 0.81
EPS (TTM) 2.56
P/E Ratio 19.13
Revenue (TTM) 1.36B
Rev Growth (5Y) +3.0%
EPS Growth (5Y) +2.9%
AlphaVal · Fair Value
What we estimate one share is worth
$56.01
Fair Value weak signal
12.6% below fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
B-
Stable Earnings Power
67.1 / 100 composite
Steady, predictable earnings power — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 1.35B 1.27B 1.30B 1.25B 1.28B 1.16B 1.24B 1.05B 1.08B 1.03B 970.64M 960.18M
Net Income 255.02M 261.82M 200.66M 184.09M 310.23M 231.36M 255.15M 41.75M 201.80M 185.86M 181.39M 206.10M
EPS 2.66 2.74 2.00 1.84 3.07 2.30 2.51 1.18 1.98 1.85 1.75 2.02
Free Cash Flow 430.26M 297.25M 336.74M 259.12M 393.30M 274.86M 214.14M 266.85M 272.93M 138.28M 114.44M 248.23M
FCF / Share 4.49 3.11 3.52 2.59 3.89 2.73 2.11 2.58 2.68 1.37 1.12 2.43
Operating CF 472.20M 327.25M 367.08M 318.58M 447.75M 343.85M 327.67M 352.20M 377.79M 360.06M 309.38M 361.55M
Total Assets 3.23B 3.13B 2.99B 2.70B 3.12B 2.94B 2.82B 2.87B 2.54B 2.32B 2.13B 1.98B
Total Debt 38.88M 46.99M 50.65M 50.94M 72.12M 81.14M 0 0 0 0 0 0
Cash & Equiv 701.89M 577.75M 817.97M 628.37M 1.23B 1.08B 805.59M 925.25M 634.37M 519.76M 534.86M 570.61M
Book Value 2.62B 2.48B 2.36B 2.25B 2.60B 2.43B 2.31B 2.19B 2.14B 1.97B 1.81B 1.71B
Return on Equity 0.10 0.11 0.09 0.08 0.12 0.10 0.11 0.02 0.09 0.09 0.10 0.12
DLB News
Dolby Laboratories Announces Conference Call and Webcast for Q3 Fiscal 2026 Financial Results
Jul 14, 2026 12:15 PM · prnewswire.com
CervoMed Announces New Clinical, Plasma Biomarker and Imaging Data at AAIC 2026 for Neflamapimod in the Treatment of Dementia with Lewy Bodies (DLB)
Jul 14, 2026 03:30 AM · globenewswire.com
Cognition Therapeutics: Clearer FDA Path, But Potential Dilution Risks Remain
Jun 26, 2026 06:07 AM · seekingalpha.com
Cognition Therapeutics Aligns on Key Aspects of Pivotal Study for Zervimesine (CT1812) in DLB Psychosis Following Receipt of FDA Meeting Minutes
Jun 24, 2026 03:30 AM · globenewswire.com
3 Audio Video Stocks to Watch as Industry Witnesses Headwinds
Jun 10, 2026 10:00 AM · zacks.com
Arista Introduces Next-Generation 1.6Terabit Portfolio for AI Fabrics
Jun 09, 2026 06:00 AM · gurufocus.com
Dolby Vision and Dolby Atmos to Power Telemundo's FIFA World Cup 2026™ Coverage on Peacock, a Streaming First
Jun 05, 2026 07:00 AM · gurufocus.com
Dolby Laboratories, Inc. (DLB) Presents at 2026 Baird Global Consumer, Technology & Services Conference Transcript
Jun 04, 2026 08:41 AM · seekingalpha.com
Dolby Laboratories, Inc. (DLB) Presents at 46th Annual William Blair Growth Stock Conference Transcript
Jun 03, 2026 09:52 AM · seekingalpha.com
GE HealthCare Focuses on Expanding Access to Nuclear Medicine Through AI, Radiopharmaceutical and Imaging Innovations
Jun 01, 2026 05:00 AM · gurufocus.com